Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin‑resistant ovarian cancer
published in: Molecular Medicine Reports
date of publication: 2014-08-14
language: English
main subject: ovarian cancer, metformin, cisplatin
Cites articles 20
- 2005-05-01
Date
Title
Article - wd:Q34426894